Article
Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition…
medRxiv · 2022 · Brusson, M.; Chalumeau, A.; Martinucci, P.; Romano, O.; Poletti, V.; Scaramuzza, S.; Ramadier, S.; Masson, C.; Ferrari, G.; Mavilio, F.; Cavazzana, M.; Amendola, M.; Miccio, A.
Key facts
| Title | Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies |
|---|---|
| First author | Brusson, M.; Chalumeau, A.; Martinucci, P.; Romano, O.; Poletti, V.; Scaramuzza, S.; Ramadier, S.; Masson, C.; Ferrari, G.; Mavilio, F.; Cavazzana, M.; Amendola, M.; Miccio, A. |
| Journal | medRxiv |
| Published | Dec 31, 2022 |
| DOI | 10.1101/2022.12.31.522279 |
| Devices mentioned | BK020041, BK110039, BK120012, BK130065, BK860041, BK900002, BK950056, BK950065, DEN000008, K010696, K012371, K022086 and 20 more |
| Product codes mentioned | DDD, DDG, GKT, LKN, IZL, JCI, JJH, JPA, JQP, KIE, KIP, KIT and 15 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1